Search | Virtual Health Library

1.

Phase 1/2 trial of avelumab combined with utomilumab (4-1BB agonist), PF-04518600 (OX40 agonist), or radiotherapy in patients with advanced gynecologic malignancies.

Knisely, Anne; Ahmed, Jibran; Stephen, Bettzy; Piha-Paul, Sarina A; Karp, Daniel; Zarifa, Abdulrazzak; Fu, Siqing; Hong, David Sanghyun; Rodon Ahnert, Jordi; Yap, Timothy A; Tsimberidou, Apostolia M; Alshawa, Anas; Dumbrava, Ecaterina E; Yang, Yali; Song, Juhee; Meric-Bernstam, Funda; Jazaeri, Amir A; Naing, Aung.

Cancer ; 130(3): 400-409, 2024 02 01.

Article in English | MEDLINE | ID: mdl-37864520

2.

First-In-Human Phase I Study of Tinengotinib (TT-00420), a Multiple Kinase Inhibitor, as a Single Agent in Patients With Advanced Solid Tumors.

Piha-Paul, Sarina A; Xu, Binghe; Dumbrava, Ecaterina E; Fu, Siqing; Karp, Daniel D; Meric-Bernstam, Funda; Hong, David S; Rodon, Jordi A; Tsimberidou, Apostolia M; Raghav, Kanwal; Ajani, Jaffer A; Conley, Anthony P; Mott, Frank; Fan, Ying; Fan, Jean; Peng, Peng; Wang, Hui; Ni, Shumao; Sun, Caixia; Qiang, Xiaoyan; Levin, Wendy J; Ngo, Brenda; Ru, Qinhua Cindy; Wu, Frank; Javle, Milind M.

Oncologist ; 29(4): e514-e525, 2024 Apr 04.

Article in English | MEDLINE | ID: mdl-38297981

3.

Innovative trial design in precision oncology.

Tsimberidou, Apostolia M; Müller, Peter; Ji, Yuan.

Semin Cancer Biol ; 84: 284-292, 2022 09.

Article in English | MEDLINE | ID: mdl-33022355

4.

Transcriptomics and solid tumors: The next frontier in precision cancer medicine.

Tsimberidou, Apostolia M; Fountzilas, Elena; Bleris, Leonidas; Kurzrock, Razelle.

Semin Cancer Biol ; 84: 50-59, 2022 09.

Article in English | MEDLINE | ID: mdl-32950605

5.

Phase 1b study of combined selinexor and eribulin for the treatment of advanced solid tumors and triple-negative breast cancer.

Nelson, Blessie Elizabeth; Saleem, Sadia; Damodaran, Senthil; Somaiah, Neeta; Piha-Paul, Sarina; Moore, Julia Ann; Yilmaz, Bulent; Ogbonna, Deby; Karp, Daniel D; Dumbrava, Ecaterina; Tsimberidou, Apostolia M; Hong, David S; Rodon Ahnert, Jordi; Milton, Denái R; Zheng, Xiaofeng; Booser, Daniel J; Ibrahim, Nuhad K; Conley, Anthony P; Bhosale, Priya; Rojas Hernandez, Cristhiam M; Tripathy, Debasish; Naing, Aung; Meric-Bernstam, Funda.

Cancer ; 129(14): 2201-2213, 2023 07 15.

Article in English | MEDLINE | ID: mdl-37016732

6.

A Phase I Trial of Bevacizumab and Temsirolimus in Combination With Valproic Acid in Advanced Solid Tumors.

Nelson, Blessie Elizabeth; Tsimberidou, Apostolia M; Fu, Xueyao; Fu, Siqing; Subbiah, Vivek; Sood, Anil K; Rodon, Jordi; Karp, Daniel D; Blumenschein, George; Kopetz, Scott; Pant, Shubham; Piha-Paul, Sarina A.

Oncologist ; 28(12): 1100-e1292, 2023 Dec 11.

Article in English | MEDLINE | ID: mdl-37311055

7.

Supportive care for the prevention of nausea, vomiting and anorexia in a phase 1B study of selinexor in advanced cancer patients: an exploratory study.

Dev, Rony; Zhong, Linda L; Zarifa, Abdulrazzak; Albittar, Aya A; Rubin, Laura; Liu, Suyu; Yap, Timothy A; Dalal, Shalini; Hui, David; Karp, Daniel D; Tsimberidou, Apostolia M; Piha-Paul, Sarina A; Ahnert, Jordi Rodon; Fu, Siqing; Meric-Bernstam, Funda; Naing, Aung.

Invest New Drugs ; 40(1): 124-133, 2022 02.

Article in English | MEDLINE | ID: mdl-34559346

8.

Dose-escalation study of vemurafenib with sorafenib or crizotinib in patients with BRAF-mutated advanced cancers.

Janku, Filip; Sakamuri, Divya; Kato, Shumei; Huang, Helen J; Call, S Greg; Naing, Aung; Holley, Veronica R; Patel, Sapna P; Amaria, Rodabe N; Falchook, Gerald S; Piha-Paul, Sarina A; Zinner, Ralph G; Tsimberidou, Apostolia M; Hong, David S; Meric-Bernstam, Funda.

Cancer ; 127(3): 391-402, 2021 02 01.

Article in English | MEDLINE | ID: mdl-33119140

9.

Overview of Ocular Side Effects of Selinexor.

Al-Zubidi, Nagham; Gombos, Dan S; Hong, David S; Subbiah, Vivek; Fu, Siqing; Ahnert, Jordi Rodon; Piha-Paul, Sarina A; Tsimberidou, Apostolia M; Karp, Daniel D; Bernstam, Funda Meric; Naing, Aung.

Oncologist ; 26(7): 619-623, 2021 07.

Article in English | MEDLINE | ID: mdl-33728727

10.

Patient-Reported Out-of-Pocket Costs and Financial Toxicity During Early-Phase Oncology Clinical Trials.

Huey, Ryan W; George, Goldy C; Phillips, Penny; White, Revenda; Fu, Siqing; Janku, Filip; Karp, Daniel D; Naing, Aung; Piha-Paul, Sarina; Subbiah, Vivek; Tsimberidou, Apostolia M; Pant, Shubham; Yap, Timothy A; Rodon, Jordi; Meric-Bernstam, Funda; Shih, Ya-Chen Tina; Hong, David S.

Oncologist ; 26(7): 588-596, 2021 07.

Article in English | MEDLINE | ID: mdl-33783054

11.

Phase 1 study of the combination of vemurafenib, carboplatin, and paclitaxel in patients with BRAF-mutated melanoma and other advanced malignancies.

Bhatty, Minny; Kato, Shumei; Piha-Paul, Sarina A; Naing, Aung; Subbiah, Vivek; Huang, Helen J; Karp, Daniel D; Tsimberidou, Apostolia M; Zinner, Ralph G; Hwu, Wen-Jen; Javle, Milind; Patel, Sapna P; Hu, Mimi I; Varadhachary, Gauri R; Conley, Anthony P; Ramzanali, Nishma M; Holley, Veronica R; Kurzrock, Razelle; Meric-Bernstam, Funda; Kwang Chae, Young; Kim, Kevin B; Falchook, Gerald S; Janku, Filip.

Cancer ; 125(3): 463-472, 2019 02 01.

Article in English | MEDLINE | ID: mdl-30383888

12.

Physiologically-based pharmacokinetic modelling to predict oprozomib CYP3A drug-drug interaction potential in patients with advanced malignancies.

Ou, Ying; Xu, Yang; Gore, Lia; Harvey, R Donald; Mita, Alain; Papadopoulos, Kyriakos P; Wang, Zhengping; Cutler, Richard E; Pinchasik, Dawn E; Tsimberidou, Apostolia M.

Br J Clin Pharmacol ; 85(3): 530-539, 2019 03.

Article in English | MEDLINE | ID: mdl-30428505

13.

A nonparametric Bayesian basket trial design.

Xu, Yanxun; Müller, Peter; Tsimberidou, Apostolia M; Berry, Donald.

Biom J ; 61(5): 1160-1174, 2019 09.

Article in English | MEDLINE | ID: mdl-29808479

14.

Phase I study of the combination of crizotinib (as a MET inhibitor) and dasatinib (as a c-SRC inhibitor) in patients with advanced cancer.

Kato, Shumei; Jardim, Denis L; Johnson, Faye M; Subbiah, Vivek; Piha-Paul, Sarina; Tsimberidou, Apostolia M; Falchook, Gerald S; Karp, Daniel; Zinner, Ralph; Wheler, Jennifer; Janku, Filip; Fu, Siqing; Lim, JoAnn; Bean, Stacie; Nguyen, Ly; Urban, Susan; Browne, Elsa; Meric-Bernstam, Funda; Hong, David S.

Invest New Drugs ; 36(3): 416-423, 2018 06.

Article in English | MEDLINE | ID: mdl-29047029

15.

Outcomes of patients ≥65 years old with advanced cancer treated on phase I trials at MD ANDERSON CANCER CENTER.

Subbiah, Ishwaria M; Wheler, Jennifer J; Hess, Kenneth R; Hong, David S; Naing, Aung; Fu, Siqing; Kurzrock, Razelle; Tsimberidou, Apostolia M.

Int J Cancer ; 140(1): 208-215, 2017 Jan 01.

Article in English | MEDLINE | ID: mdl-27599876

16.

Post-Discharge Survival Outcomes of Patients with Advanced Cancer from the University of Texas MD Anderson Cancer Center Investigational Cancer Therapeutics (Phase I Trials) Inpatient Unit.

Kinahan, Holly; Maiti, Abhishek; Hess, Kenneth; Dempsey, Jennifer; Beatty, Laura; Baldwin, Sarah; Hong, David S; Naing, Aung; Fu, Siqing; Tsimberidou, Apostolia M; Piha-Paul, Sarina; Janku, Filip; Karp, Daniel; Reddy, Suresh; Yennu, Sriram; Epner, Daniel; Bruera, Eduardo; Meric-Bernstam, Funda; Falchook, Gerald; Subbiah, Vivek.

Oncology ; 92(1): 14-20, 2017.

Article in English | MEDLINE | ID: mdl-27802448

17.

Sleep quality and its association with fatigue, symptom burden, and mood in patients with advanced cancer in a clinic for early-phase oncology clinical trials.

George, Goldy C; Iwuanyanwu, Eucharia C; Anderson, Karen O; Yusuf, Alizeh; Zinner, Ralph G; Piha-Paul, Sarina A; Tsimberidou, Apostolia M; Naing, Aung; Fu, Siqing; Janku, Filip; Subbiah, Vivek; Cleeland, Charles S; Mendoza, Tito R; Hong, David S.

Cancer ; 122(21): 3401-3409, 2016 Nov 15.

Article in English | MEDLINE | ID: mdl-27412379

18.

A phase I trial of combination trastuzumab, lapatinib, and bevacizumab in patients with advanced cancer.

Falchook, Gerald S; Moulder, Stacy; Naing, Aung; Wheler, Jennifer J; Hong, David S; Piha-Paul, Sarina A; Tsimberidou, Apostolia M; Fu, Siqing; Zinner, Ralph; Janku, Filip; Jiang, Yunfang; Huang, Mei; Parkhurst, Kristin L; Kurzrock, Razelle.

Invest New Drugs ; 33(1): 177-86, 2015 Feb.

Article in English | MEDLINE | ID: mdl-25323060

19.

Dual antiangiogenic inhibition: a phase I dose escalation and expansion trial targeting VEGF-A and VEGFR in patients with advanced solid tumors.

Falchook, Gerald S; Wheler, Jennifer J; Naing, Aung; Piha-Paul, Sarina A; Fu, Siqing; Tsimberidou, Apostolia M; Hong, David S; Janku, Filip; Zinner, Ralph; Jiang, Yunfang; Huang, Mei; Lin, Quan; Parkhurst, Kristin; Kurzrock, Razelle.

Invest New Drugs ; 33(1): 215-24, 2015 Feb.

Article in English | MEDLINE | ID: mdl-25363205

20.

Xilonix, a novel true human antibody targeting the inflammatory cytokine interleukin-1 alpha, in non-small cell lung cancer.

Hong, David S; Janku, Filip; Naing, Aung; Falchook, Gerald S; Piha-Paul, Sarina; Wheler, Jennifer J; Fu, Siqing; Tsimberidou, Apostolia M; Stecher, Michael; Mohanty, Prasant; Simard, John; Kurzrock, Razelle.

Invest New Drugs ; 33(3): 621-31, 2015 Jun.

Article in English | MEDLINE | ID: mdl-25822109

Virtual Health Library

United States - Mexico Border

Your selection (0)

Export format:

Export: